Aspirin Treatment Failure Warning
Treatment failures occur with any drug and aspirin is no exception.
Evidence is growing that some people will not respond to the anti-coagulant
action of aspirin and the drug will not protect against cardiovascular
events despite its regular intake.
Professor Andrew Szczeklik from Poland and Professor Graeme Hankey
from Western Australia will present the latest findings on aspirin
resistance at the XXth Congress of the International Society of
Thrombosis and Haemostasis today.
"There are at least two possible explanations for the aspirin-resistance
phenomenon," said Professor Szczeklik. "One is high levels of
blood cholesterol, which can in itself promote coagulation events
in the blood stream. In patients with high cholesterol levels,
aspirin in in normal doses has hardly any anti-clotting effects,
whereas treatment with a statin (inhibitor of cholesterol) significantly
reduces blood clotting. In patients with coronary heart disease,
aspirin exerts it anti-coagulant effects only when blood cholesterol
is in the 'normal' range."
Szczeklik went onto say, "A patients genetic make-up may alter
their response to aspirin resistance.. For example, in coronary
heart disease patients carrying one particular gene are resistant
to the anti-coagulant action of aspirin and are at increased risk
of an acute coronary event."
Perth researcher, Professor Graeme Hankey, has shown that patients
who show evidence of aspirin resistance do respond well to another
drug called Clopidogrel.
"Clopidogrel had anti-clotting and anti-inflammatory effects
in patients with diseased arteries. These effects were greatest
in the aspirin-resistant patients," said Hankey.
"The use of aspirin has risen dramatically in Australia in the
late 1990's. This is why it is vital that aspirin resistance is
considered when implementing anti-clotting therapy. Present data
indicate that this particularly applies to survivors of a heart
attack or unstable angina, patients receiving bypass surgery as
well as people with high cholesterol," reported Hankey.
Reference
Source 125
August
9, 2005
For
more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|